CNS dispatches from Jefferies: Acadia’s search for deals, Alto’s psychiatry question and ProMIS’ Alzheimer’s ambitions
The chaotic environs of this year’s Jefferies Healthcare conference, held earlier this week in London, attracted a number of drugmakers active in the central nervous system (CNS) and psychiatry space. Endpoints News ...
comments(0)
5-min edit window · permanent after that